事業内容:
Cambridge-based Undecimal Bio, a spin-out from Eleven Therapeutics advancing targeted delivery of siRNA therapeutics, today announced a €16 million ($18 million) Seed financing round to expand DELiveri, its…
基本情報:
本社: イギリス
資金調達:
€16M · Seed · 2026年10月









